Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 69.94B | 69.23B | 65.45B | 58.76B | 52.15B | 49.91B |
Gross Profit | 10.62B | 10.68B | 10.04B | 10.57B | 9.63B | 5.66B |
EBITDA | 9.32B | 8.83B | 7.50B | 8.07B | 7.65B | 2.07B |
Net Income | 4.43B | 4.23B | 3.79B | 4.25B | 4.21B | -1.17B |
Balance Sheet | ||||||
Total Assets | 132.40B | 129.21B | 118.87B | 115.94B | 107.05B | 110.09B |
Cash, Cash Equivalents and Short-Term Investments | 17.98B | 19.18B | 18.83B | 18.25B | 16.43B | 16.52B |
Total Debt | 11.21B | 11.28B | 13.59B | 10.98B | 13.46B | 15.62B |
Total Liabilities | 110.31B | 109.52B | 101.14B | 102.96B | 97.56B | 103.64B |
Stockholders Equity | 22.00B | 19.61B | 17.70B | 12.95B | 9.47B | 6.45B |
Cash Flow | ||||||
Free Cash Flow | 5.45B | 3.73B | 3.35B | 3.82B | 2.71B | -7.18B |
Operating Cash Flow | 9.22B | 7.40B | 6.41B | 6.29B | 4.64B | -5.42B |
Investing Cash Flow | -6.48B | -6.65B | -4.13B | -3.11B | -2.72B | 4.13B |
Financing Cash Flow | -2.58B | -2.57B | -1.28B | -2.12B | -2.18B | 6.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $145.08B | 32.67 | 21.75% | 1.57% | 5.16% | 12.89% | |
70 Outperform | €116.48B | 62.44 | -6.13% | 1.04% | 17.19% | -119.44% | |
70 Neutral | €23.64B | 25.71 | 15.30% | 1.56% | 29.86% | 37.44% | |
69 Neutral | €51.58B | 49.77 | 14.05% | 2.27% | 11.66% | 3.13% | |
58 Neutral | HK$14.16B | 4.43 | -3.01% | 7.12% | 3.67% | -54.16% |